Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Exchange Rates
Interest Rates
Futures
Economy
Global Metrics

Agenus PE Ratio 2006-2019 | AGEN

Current and historical p/e ratio for Agenus (AGEN) from 2006 to 2019. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Agenus PE ratio as of December 06, 2019 is 0.00.
  
Agenus PE Ratio Historical Data
Date Stock Price TTM Net EPS PE Ratio
2019-12-06 3.91 0.00
2019-09-30 2.58 $-0.99 0.00
2019-06-30 3.00 $-0.95 0.00
2019-03-31 2.97 $-0.81 0.00
2018-12-31 2.38 $-1.46 0.00
2018-09-30 2.14 $-1.41 0.00
2018-06-30 2.27 $-1.49 0.00
2018-03-31 4.71 $-1.57 0.00
2017-12-31 3.26 $-1.22 0.00
2017-09-30 4.41 $-1.17 0.00
2017-06-30 3.91 $-1.27 0.00
2017-03-31 3.77 $-1.28 0.00
2016-12-31 4.12 $-1.47 0.00
2016-09-30 7.18 $-1.35 0.00
2016-06-30 4.05 $-1.04 0.00
2016-03-31 4.16 $-1.24 0.00
2015-12-31 4.54 $-1.15 0.00
2015-09-30 4.60 $-1.38 0.00
2015-06-30 8.63 $-1.35 0.00
2015-03-31 5.13 $-0.94 0.00
2014-12-31 3.97 $-0.67 0.00
2014-09-30 3.11 $-0.42 0.00
2014-06-30 3.22 $-0.53 0.00
2014-03-31 3.17 $-0.81 0.00
2013-12-31 2.64 $-1.15 0.00
2013-09-30 2.77 $-1.22 0.00
2013-06-30 3.79 $-1.22 0.00
2013-03-31 3.89 $-1.13 0.00
2012-12-31 4.10 $-0.49 0.00
2012-09-30 4.61 $-0.55 0.00
2012-06-30 5.24 $-0.59 0.00
2012-03-31 6.60 $-0.58 0.00
2011-12-31 2.00 $-1.17 0.00
2011-09-30 2.82 $-1.06 0.00
2011-06-30 4.68 $-1.14 0.00
2011-03-31 5.46 $-1.14 0.00
2010-12-31 6.06 $-1.44 0.00
2010-09-30 5.94 $-1.14 0.00
2010-06-30 4.87 $-1.56 0.00
2010-03-31 4.36 $-2.28 0.00
2009-12-31 3.84 $-2.52 0.00
2009-09-30 12.42 $-2.22 0.00
2009-06-30 12.54 $-2.46 0.00
2009-03-31 2.94 $-2.58 0.00
2008-12-31 2.88 $-2.94 0.00
2008-09-30 9.48 $-4.32 0.00
2008-06-30 11.58 $-4.80 0.00
2008-03-31 14.16 $-4.98 0.00
2007-12-31 12.24 $-4.92 0.00
2007-09-30 14.22 $-5.52 0.00
2007-06-30 17.16 $-5.46 0.00
2007-03-31 13.38 $-6.00 0.00
2006-12-31 10.98 $-7.02 0.00
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.537B $0.037B
Agenus Inc., formerly known as Antigenics Inc., is engaged in the discovery, development and commercialization of immunotherapeutics for the treatment of life threatening and chronic medical conditions. Immunotherapeutics are drugs that work by modulating the immune system to fight diseases. The Company's product line includes Oncophage vaccine, a patient-specific therapeutic cancer vaccine. The Company is also developing Prophage, patient-specific therapeutic cancer vaccine; QS-21, vaccine adjuvant; and HerpV, a polyvalent off-the-shelf therapeutic heat shock protein-based vaccine for treatment of genital herpes which are all in the clinical testing stages. Agenus Inc. is headquartered in Lexington, Massachusetts.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $138.902B 16.00
CSL (CSLLY) Australia $87.394B 0.00
Gilead Sciences (GILD) United States $84.866B 10.51
Vertex Pharmaceuticals (VRTX) United States $57.409B 58.60
Biogen (BIIB) United States $54.179B 9.30
Illumina (ILMN) United States $47.991B 52.66
Regeneron Pharmaceuticals (REGN) United States $40.872B 17.90
Alexion Pharmaceuticals (ALXN) United States $25.203B 12.45
Incyte (INCY) United States $20.351B 47.24
Seattle Genetics (SGEN) United States $20.138B 0.00
SINO PHARMACEUT (SBMFF) Hong Kong, SAR China $17.624B 0.00
Genmab (GNMSF) Denmark $14.761B 65.20
BioMarin Pharmaceutical (BMRN) United States $14.356B 0.00
Alnylam Pharmaceuticals (ALNY) United States $13.798B 0.00
Galapagos (GLPG) Belgium $11.704B 30.16
Exact Sciences (EXAS) United States $11.197B 0.00
Bio-Rad Laboratories (BIO.B) United States $10.393B 49.88
QIAGEN (QGEN) Netherlands $9.429B 30.74
BeiGene (BGNE) Cayman Islands $8.976B 0.00
Bio-Techne Corp (TECH) United States $8.358B 55.95
Sarepta Therapeutics (SRPT) United States $8.159B 0.00
Amarin (AMRN) Ireland $8.019B 0.00
ACADIA Pharmaceuticals (ACAD) United States $7.917B 0.00
Guardant Health (GH) United States $6.947B 0.00
Medicines (MDCO) United States $6.714B 0.00
Moderna (MRNA) United States $6.312B 0.00
Horizon Therapeutics Public (HZNP) Ireland $6.037B 15.35
Reata Pharmaceuticals (RETA) United States $6.034B 0.00
ARGENX SE-ADR (ARGX) Netherlands $5.618B 0.00
BioNTech SE (BNTX) Germany $5.514B 0.00
Exelixis (EXEL) United States $5.275B 14.84
Repligen (RGEN) United States $4.701B 85.19
China Biologic Products (CBPO) China $4.603B 25.93
Ascendis Pharma (ASND) Denmark $4.532B 0.00
Bluebird Bio (BLUE) United States $4.394B 0.00
Spark Therapeutics (ONCE) United States $4.263B 0.00
MorphoSys AG (MOR) Germany $4.153B 0.00
Mirati Therapeutics (MRTX) United States $4.047B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $3.995B 0.00
Immunomedics (IMMU) United States $3.981B 0.00
Blueprint Medicines (BPMC) United States $3.861B 0.00
Adaptive Biotechnologies (ADPT) United States $3.613B 0.00
Intercept Pharmaceuticals (ICPT) United States $3.518B 0.00
Alkermes (ALKS) Ireland $3.300B 0.00
MyoKardia (MYOK) United States $3.117B 0.00
Genmab (GMAB) Denmark $3.064B 6.31
UniQure (QURE) Netherlands $2.881B 0.00
Emergent Biosolutions (EBS) United States $2.838B 28.19
Halozyme Therapeutics (HALO) United States $2.808B 0.00
NeoGenomics (NEO) United States $2.779B 147.89
Acceleron Pharma (XLRN) United States $2.648B 0.00
Amicus Therapeutics (FOLD) United States $2.576B 0.00
Ultragenyx Pharmaceutical (RARE) United States $2.484B 0.00
Arena Pharmaceuticals (ARNA) United States $2.408B 5.60
Zai Lab (ZLAB) China $2.399B 0.00
RA PHARMCTL INC (RARX) United States $2.216B 0.00
Insmed (INSM) United States $2.064B 0.00
Myriad Genetics (MYGN) United States $1.905B 28.14
Ligand Pharmaceuticals (LGND) United States $1.897B 36.49
Dicerna Pharmaceuticals (DRNA) United States $1.822B 0.00
Momenta Pharmaceuticals (MNTA) United States $1.782B 0.00
Denali Therapeutics (DNLI) United States $1.754B 0.00
Epizyme (EPZM) United States $1.659B 0.00
Akcea Therapeutics (AKCA) United States $1.656B 0.00
Zymeworks (ZYME) Canada $1.648B 0.00
REGENXBIO (RGNX) United States $1.647B 0.00
Editas Medicine (EDIT) United States $1.586B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $1.402B 0.00
Athenex (ATNX) United States $1.376B 0.00
Alector (ALEC) United States $1.362B 0.00
Sangamo Therapeutics (SGMO) United States $1.352B 0.00
Innoviva (INVA) United States $1.308B 3.85
Arvinas (ARVN) United States $1.297B 0.00
Coherus BioSciences (CHRS) United States $1.273B 0.00
Principia Biopharma (PRNB) United States $1.226B 0.00
Orchard Therapeutics (ORTX) United Kingdom $1.151B 0.00
Zealand Pharma (ZLDPF) Denmark $1.129B 0.00
WAVE Life Sciences (WVE) Singapore $1.109B 0.00
Zealand Pharma (ZEAL) Denmark $1.046B 0.00
Fate Therapeutics (FATE) United States $1.033B 0.00
Precision BioSciences (DTIL) United States $0.998B 0.00
Pharming Group (PHGUF) Netherlands $0.968B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.934B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.932B 7.83
Codexis (CDXS) United States $0.909B 0.00
Achillion Pharmaceuticals (ACHN) United States $0.864B 0.00
BAVARIAN NORDIC (BVNRY) Denmark $0.846B 0.00
Intellia Therapeutics (NTLA) United States $0.836B 0.00
Vericel (VCEL) United States $0.833B 310.50
MiMedx (MDXG) United States $0.821B 0.00
Anika Therapeutics (ANIK) United States $0.820B 26.61
Twist Bioscience (TWST) United States $0.813B 0.00
Heska (HSKA) United States $0.749B 191.46
Adverum Biotechnologies (ADVM) United States $0.738B 0.00
Revance Therapeutics (RVNC) United States $0.736B 0.00
ANI Pharmaceuticals (ANIP) United States $0.718B 12.25
DBV Technologies S.A (DBVT) France $0.717B 0.00
UROGEN PHARMA (URGN) United States $0.685B 0.00
Cara Therapeutics (CARA) United States $0.671B 0.00
Mesoblast (MESO) Australia $0.665B 0.00
Cellectis S.A (CLLS) France $0.623B 0.00
GENFIT S.A (GNFT) France $0.596B 0.00
AC Immune SA (ACIU) Switzerland $0.593B 13.72
Autolus Therapeutics (AUTL) United Kingdom $0.592B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.590B 0.00
Kadmon Holdings (KDMN) United States $0.584B 0.00
Sorrento Therapeutics (SRNE) United States $0.579B 0.00
BioDelivery Sciences (BDSI) United States $0.576B 0.00
PHARMA MAR SA (PHMMF) Spain $0.570B 0.00
Retrophin (RTRX) United States $0.570B 0.00
Intra-Cellular Therapies (ITCI) United States $0.564B 0.00
Cytokineticsorporated (CYTK) United States $0.557B 0.00
Clovis Oncology (CLVS) United States $0.527B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.518B 3.58
Stemline Therapeutics (STML) United States $0.517B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $0.514B 0.00
Prothena (PRTA) Ireland $0.513B 0.00
Dynavax Technologies (DVAX) United States $0.478B 0.00
Sinovac Biotech (SVA) China $0.460B 0.00
Bellus Health (BLU) Canada $0.402B 0.00
Merus (MRUS) Netherlands $0.381B 0.00
AnaptysBio (ANAB) United States $0.380B 0.00
Arcus Biosciences (RCUS) United States $0.377B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.375B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.361B 0.00
Cellular Biomedicine (CBMG) United States $0.337B 0.00
PDL BioPharma (PDLI) United States $0.337B 8.43
OSMOTICA PHARM (OSMT) United States $0.335B 0.00
Avid Bioservices (CDMO) United States $0.326B 0.00
Gritstone Oncology (GRTS) United States $0.325B 0.00
Starpharma Holdings (SPHRY) Australia $0.320B 0.00
Puma Biotechnology (PBYI) United States $0.307B 0.00
Kindred Biosciences (KIN) United States $0.303B 0.00
Geron (GERN) United States $0.302B 0.00
Kamada (KMDA) Israel $0.297B 8.67
CytomX Therapeutics (CTMX) United States $0.286B 0.00
Compugen (CGEN) Israel $0.276B 0.00
Cue Biopharma (CUE) United States $0.269B 0.00
Albireo Pharma (ALBO) United States $0.264B 0.00
Seres Therapeutics (MCRB) United States $0.257B 0.00
ADMA Biologics Inc (ADMA) United States $0.256B 0.00
Scholar Rock Holding (SRRK) United States $0.252B 0.00
MannKind (MNKD) United States $0.250B 0.00
Inovio Pharmaceuticals (INO) United States $0.239B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.236B 0.00
Sutro Biopharma (STRO) United States $0.233B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.228B 0.00
Spero Therapeutics (SPRO) United States $0.228B 0.00
ChromaDex (CDXC) United States $0.228B 0.00
Biofrontera AG (BFRA) Germany $0.226B 0.00
XOMA (XOMA) United States $0.223B 0.00
Theratechnologies (THTX) Canada $0.221B 0.00
Exicure (XCUR) United States $0.220B 0.00
Protagonist Therapeutics (PTGX) United States $0.209B 0.00
Athersys (ATHX) United States $0.208B 0.00
Senesco Technologies (ELOX) United States $0.205B 0.00
Mersana Therapeutics (MRSN) United States $0.203B 0.00
POXEL SA FRANCE (PXXLF) France $0.203B 0.00
Syros Pharmaceuticals (SYRS) United States $0.195B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.188B 0.00
IVERIC Bio (ISEE) United States $0.183B 0.00
Proteostasis Therapeutics (PTI) United States $0.182B 0.00
Cerecor (CERC) United States $0.176B 0.00
Affimed (AFMD) Germany $0.174B 0.00
Dyadic (DYAI) United States $0.165B 0.00
Alcobra (ARCT) United States $0.162B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.162B 0.00
ARAVIVE, INC (ARAV) United States $0.157B 0.00
Aquinox Pharmaceuticals (NLTX) United States $0.156B 0.00
NantKwest (NK) United States $0.155B 0.00
VBI Vaccines (VBIV) United States $0.154B 0.00
Abeona Therapeutics (ABEO) United States $0.153B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.149B 0.00
Five Prime Therapeutics (FPRX) United States $0.142B 0.00
Fortress Biotech (FBIO) United States $0.141B 0.00
Aptinyx (APTX) United States $0.139B 0.00
TELA Bio (TELA) United States $0.136B 0.00
Newron Pharmaceuticals SpA (NWPHF) Italy $0.134B 0.00
Arsanis (XFOR) United States $0.133B 0.00
Northwest Biotherapeutics (NWBO) United States $0.132B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.132B 0.00
Prometic Life Sciences (LMNL) Canada $0.131B 0.00
Arbutus Biopharma (ABUS) Canada $0.130B 0.00
Enzo Biochem (ENZ) United States $0.130B 0.00
Windtree Therapeutics (WINT) United States $0.129B 0.00
Celyad SA (CYAD) Belgium $0.125B 0.00
SESEN BIO, INC (SESN) United States $0.124B 0.00
Nicox SA (NICXF) France $0.122B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.121B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.117B 0.00
Novavax (NVAX) United States $0.116B 0.00
Menlo Therapeutics (MNLO) United States $0.104B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.102B 0.00
Verastem (VSTM) United States $0.098B 0.00
Strongbridge Biopharma (SBBP) United States $0.098B 2.62
PHASEBIO PHARMA (PHAS) United States $0.096B 0.00
Aduro Biotech (ADRO) United States $0.093B 0.00
Antibe Therapeutics (ATBPF) Canada $0.093B 0.00
Emmaus Life Sciences (EMMA) United States $0.092B 0.00
Adocia (ADOCY) France $0.086B 0.00
OvaScience (MLND) United States $0.084B 0.00
Acorda Therapeutics (ACOR) United States $0.082B 0.00
VTv Therapeutics (VTVT) United States $0.081B 0.00
Liquidia Technologies (LQDA) United States $0.076B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.076B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.076B 0.00
Synlogic (SYBX) United States $0.075B 0.00
Selecta Biosciences (SELB) United States $0.073B 0.00
Vaccinex (VCNX) United States $0.071B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.068B 0.00
Clearside Biomedical (CLSD) United States $0.067B 0.00
Trevena (TRVN) United States $0.065B 0.00
Prima BioMed (IMMP) Australia $0.064B 0.00
Organovo Holdings (ONVO) United States $0.064B 0.00
Catalyst Biosciences (CBIO) United States $0.063B 0.00
Pluristem Therapeutics (PSTI) Israel $0.060B 0.00
Spring Bank Pharmaceuticals (SBPH) United States $0.057B 0.00
Merrimack Pharmaceuticals (MACK) United States $0.057B 0.00
NewLink Genetics (NLNK) United States $0.057B 0.00
Applied Genetic Technologies (AGTC) United States $0.052B 0.00
Idera Pharmaceuticals (IDRA) United States $0.052B 0.00
Curis (CRIS) United States $0.052B 0.00
Checkpoint Therapeutics (CKPT) United States $0.048B 0.00
AquaBounty Technologies (AQB) United States $0.048B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.045B 0.00
Vascular Biogenics (VBLT) Israel $0.044B 0.00
AIT Therapeutics (XAIR) United States $0.044B 0.00
Orgenesis (ORGS) United States $0.044B 2.83
Celldex Therapeutics (CLDX) United States $0.041B 0.00
Alimera Sciences (ALIM) United States $0.037B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.036B 0.00
Stellar Biotechnologies (EDSA) Canada $0.035B 0.00
DiaMedica Therapeutics (DMAC) United States $0.034B 0.00
Evogene (EVGN) Israel $0.033B 0.00
Celsion (CLSN) United States $0.033B 0.00
Oncobiologics (OTLK) United States $0.031B 0.00
Bionano Genomics (BNGO) United States $0.030B 0.00
VIVUS (VVUS) United States $0.029B 0.00
Fibrocell Science Inc (FCSC) United States $0.029B 16.61
Apricus Biosciences (SEEL) United States $0.029B 0.00
Aptevo Therapeutics (APVO) United States $0.027B 0.00
Caladrius Biosciences (CLBS) United States $0.027B 0.00
BioCardia (BCDA) United States $0.027B 0.00
INNOVATE BIOPHARMACEUTICALS, INC (INNT) United States $0.026B 0.00
Novogen (KZIA) Australia $0.026B 0.00
Entera Bio (ENTX) Israel $0.026B 0.00
Soligenix (SNGX) United States $0.024B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.023B 0.00
Unum Therapeutics (UMRX) United States $0.021B 0.00
CollPlant Holdings (CLGN) Israel $0.019B 0.00
VistaGen Therapeutics (VTGN) United States $0.019B 0.00
Signal Genetics (MGEN) United States $0.018B 0.00
Pulmatrix (PULM) United States $0.017B 0.00
AEterna Zentaris (AEZS) United States $0.017B 0.00
Aytu Bioscience (AYTU) United States $0.015B 0.00
TOCAGEN INC (TOCA) United States $0.015B 0.00
IMMURON (IMRN) Australia $0.014B 0.00
Advaxis (ADXS) United States $0.013B 0.00
Prana Biotechnology (ATHE) Australia $0.013B 0.00
MYOS RENS Technology (MYOS) United States $0.013B 0.00
Titan Pharmaceuticals (TTNP) United States $0.011B 0.00
TrovaGene (TROV) United States $0.010B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.010B 0.00
TRACON Pharmaceuticals (TCON) United States $0.010B 0.00
Cesca Therapeutics (THMO) United States $0.008B 0.00
Genetic Technologies (GENE) Australia $0.008B 0.00
Cleveland BioLabs (CBLI) United States $0.007B 0.00
Benitec Biopharma (BNTC) Australia $0.007B 0.00
Neuralstem (SNCA) United States $0.004B 0.00